Opinion|Videos|August 27, 2024
Choosing MDS Therapies: Risk-Based Approaches
Medical experts discuss risk-based approaches to choosing MDS therapies.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Provide a high level overview of treatment approaches for both lower and higher risk MDS.
- What are the key considerations when selecting between different treatment options for lower risk MDS?
- Please include a discussion of when hypomethylating agents (HMAs) would be used in lower risk disease.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently
2
Chemo-Free Options Abound for Transplant-Ineligible MCL, Kumar Explains
3
Defunding Co-Payment Assistance Disrupted nAMD Care
4
Study Finds Flaw in Method for Key Oncology Value-Based Care Model
5